BetterLife Pharma issues 107,958,160 pre-funded warrants at nominal exercise price of CDN$0.00001

• BetterLife Pharma closed a public offering that issued 107,958,160 pre-funded common share purchase warrants priced at CDN$0.25.
• Each pre-funded warrant is exercisable at any time for one common share at an exercise price of CDN$0.00001.
• Agents also received 38,284,189 broker warrants exercisable for common shares at CDN$0.25 through Sept. 17, 2029.
• The pre-funded warrants will not be listed on any stock exchange.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BetterLife Pharma Inc. published the original content used to generate this news brief on September 17, 2026, and is solely responsible for the information contained therein.